206 related articles for article (PubMed ID: 29372251)
1. Temporal Expression of Genes in Biofilm-Forming Ocular Candida albicans Isolated From Patients With Keratitis and Orbital Cellulitis.
Ranjith K; Kalyana Chakravarthy S; Adicherla H; Sharma S; Shivaji S
Invest Ophthalmol Vis Sci; 2018 Jan; 59(1):528-538. PubMed ID: 29372251
[TBL] [Abstract][Full Text] [Related]
2. Candida species isolated from different body sites and their antifungal susceptibility pattern: Cross-analysis of Candida albicans and Candida glabrata biofilms.
Cataldi V; Di Campli E; Fazii P; Traini T; Cellini L; Di Giulio M
Med Mycol; 2017 Aug; 55(6):624-634. PubMed ID: 27915303
[TBL] [Abstract][Full Text] [Related]
3. Candida Species From Eye Infections: Drug Susceptibility, Virulence Factors, and Molecular Characterization.
Ranjith K; Sontam B; Sharma S; Joseph J; Chathoth KN; Sama KC; Murthy SI; Shivaji S
Invest Ophthalmol Vis Sci; 2017 Aug; 58(10):4201-4209. PubMed ID: 28837732
[TBL] [Abstract][Full Text] [Related]
4. The Activity of Fungichromin against the Formation of Candida albicans Biofilm.
An D; Wang X; Li J; Jiang S; Ma X; Zhang H; Shi H; Sun H; Ye L; Li J
Biol Pharm Bull; 2016 Dec; 39(12):1948-1954. PubMed ID: 27615430
[TBL] [Abstract][Full Text] [Related]
5. Development of
Lee HS; Kim Y
J Microbiol Biotechnol; 2018 Mar; 28(3):482-490. PubMed ID: 29316739
[No Abstract] [Full Text] [Related]
6. Relative Abundances of Candida albicans and Candida glabrata in
Olson ML; Jayaraman A; Kao KC
Appl Environ Microbiol; 2018 Apr; 84(8):. PubMed ID: 29427422
[No Abstract] [Full Text] [Related]
7. The calcineruin inhibitor cyclosporine a synergistically enhances the susceptibility of Candida albicans biofilms to fluconazole by multiple mechanisms.
Jia W; Zhang H; Li C; Li G; Liu X; Wei J
BMC Microbiol; 2016 Jun; 16(1):113. PubMed ID: 27316338
[TBL] [Abstract][Full Text] [Related]
8. Keratitis-associated fungi form biofilms with reduced antifungal drug susceptibility.
Zhang X; Sun X; Wang Z; Zhang Y; Hou W
Invest Ophthalmol Vis Sci; 2012 Nov; 53(12):7774-8. PubMed ID: 23099491
[TBL] [Abstract][Full Text] [Related]
9. Chemical composition and antifungal activity of Satureja hortensis L. essentiall oil against planktonic and biofilm growth of Candida albicans isolates from buccal lesions of HIV(+) individuals.
Sharifzadeh A; Khosravi AR; Ahmadian S
Microb Pathog; 2016 Jul; 96():1-9. PubMed ID: 27126187
[TBL] [Abstract][Full Text] [Related]
10. Inhibitory Effect of Sophorolipid on Candida albicans Biofilm Formation and Hyphal Growth.
Haque F; Alfatah M; Ganesan K; Bhattacharyya MS
Sci Rep; 2016 Mar; 6():23575. PubMed ID: 27030404
[TBL] [Abstract][Full Text] [Related]
11. Comparative antifungal susceptibility analysis of Candida albicans versus non-albicans Candida corneal isolates.
Spierer O; Dugar J; Miller D; OʼBrien TP
Cornea; 2015 May; 34(5):576-9. PubMed ID: 25826327
[TBL] [Abstract][Full Text] [Related]
12. Biofilms of Candida spp. from the ocular conjunctiva of horses with reduced azole susceptibility: a complicating factor for the treatment of keratomycosis?
Brilhante RSN; Bittencourt PV; de Souza Collares Castelo-Branco D; de Melo Guedes GM; de Oliveira JS; Alencar LP; de Aguiar Cordeiro R; Pinheiro M; Nogueira-Filho EF; de Aquino Pereira-Neto W; Sidrim JJC; Rocha MFG
Vet Ophthalmol; 2017 Nov; 20(6):539-546. PubMed ID: 28417524
[TBL] [Abstract][Full Text] [Related]
13. Effects of magnolol and honokiol on adhesion, yeast-hyphal transition, and formation of biofilm by Candida albicans.
Sun L; Liao K; Wang D
PLoS One; 2015; 10(2):e0117695. PubMed ID: 25710475
[TBL] [Abstract][Full Text] [Related]
14. Expression of SAP5 and SAP9 in Candida albicans biofilms: comparison of bloodstream isolates with isolates from other sources.
Joo MY; Shin JH; Jang HC; Song ES; Kee SJ; Shin MG; Suh SP; Ryang DW
Med Mycol; 2013 Nov; 51(8):892-6. PubMed ID: 23971863
[TBL] [Abstract][Full Text] [Related]
15. The expression of genes involved in the ergosterol biosynthesis pathway in Candida albicans and Candida dubliniensis biofilms exposed to fluconazole.
Borecká-Melkusová S; Moran GP; Sullivan DJ; Kucharíková S; Chorvát D; Bujdáková H
Mycoses; 2009 Mar; 52(2):118-28. PubMed ID: 18627475
[TBL] [Abstract][Full Text] [Related]
16. Biofilm formation by the fungal pathogen Candida albicans: development, architecture, and drug resistance.
Chandra J; Kuhn DM; Mukherjee PK; Hoyer LL; McCormick T; Ghannoum MA
J Bacteriol; 2001 Sep; 183(18):5385-94. PubMed ID: 11514524
[TBL] [Abstract][Full Text] [Related]
17. Utilising polyphenols for the clinical management of Candida albicans biofilms.
Shahzad M; Sherry L; Rajendran R; Edwards CA; Combet E; Ramage G
Int J Antimicrob Agents; 2014 Sep; 44(3):269-73. PubMed ID: 25104135
[TBL] [Abstract][Full Text] [Related]
18. Candida albicans strain-dependent virulence and Rim13p-mediated filamentation in experimental keratomycosis.
Mitchell BM; Wu TG; Jackson BE; Wilhelmus KR
Invest Ophthalmol Vis Sci; 2007 Feb; 48(2):774-80. PubMed ID: 17251477
[TBL] [Abstract][Full Text] [Related]
19. Effects of lactoferricin B against keratitis-associated fungal biofilms.
Sengupta J; Saha S; Khetan A; Sarkar SK; Mandal SM
J Infect Chemother; 2012 Oct; 18(5):698-703. PubMed ID: 22410856
[TBL] [Abstract][Full Text] [Related]
20. BDSF inhibits Candida albicans adherence to urinary catheters.
Tian J; Weng LX; Zhang YQ; Wang LH
Microb Pathog; 2013 Nov; 64():33-8. PubMed ID: 23948468
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
